SCHEMBL2407551

SCHEMBL2407551

[CH2]C(O)c1ccc(OC)c(OC)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 1/20 0.58
▸ PPARD Q03181 1/20 0.58
▸ PPARA Q07869 1/20 0.58
▸ ACHE P22303 4/20 0.53
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ CYP1A2 P05177 2/20 0.51
▸ CYP2C9 P11712 2/20 0.51
▸ CYP2C19 P33261 2/20 0.51
▸ NPSR1 Q6W5P4 2/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ TUBB4A P04350 2/20 0.46
▸ TUBB P07437 2/20 0.46
▸ TUBA3C P0DPH7 2/20 0.46
▸ TUBA1B P68363 2/20 0.46
▸ TUBA4A P68366 2/20 0.46
▸ TUBB4B P68371 2/20 0.46
▸ TUBB3 Q13509 2/20 0.46
▸ TUBB2A Q13885 2/20 0.46
▸ TUBB8 Q3ZCM7 2/20 0.46
▸ TUBA3E Q6PEY2 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11383561 0.84 TSHR (0.64) ACHENPSR1KMT2ATUBB4ATUBB
SCHEMBL6656697 0.83 PPARG (0.61) PPARGPPARDPPARAACHEL3MBTL1
SCHEMBL8909353 0.83 PPARG (0.52) PPARGPPARDPPARAACHEL3MBTL1
SCHEMBL16878959 0.82 LMNA (0.47) PPARGPPARDPPARAKMT2ATUBB4A
SCHEMBL6779179 0.81 ACHE (0.50) PPARGPPARDPPARAACHEL3MBTL1
SCHEMBL8238025 0.81 PPARG (0.59) PPARGPPARDPPARAACHEL3MBTL1
SCHEMBL670305 0.81 PPARG (0.59) PPARGPPARDPPARAACHEL3MBTL1
SCHEMBL27710622 0.79 PPARG (0.58) PPARGPPARDPPARAACHEL3MBTL1
SCHEMBL30176234 0.79 PPARG (0.58) PPARGPPARDPPARAACHEL3MBTL1
SCHEMBL758673 0.79 PPARG (0.68) PPARGPPARDPPARAACHEL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110212968-A1 PHENETHYLAMIDE DERIVATIVES AND THEIR HETEROCYCLIC ANALOGUES ACTELION PHARMACEUTICALS LTD. (CH) 2011-09-01 — — US disclosed
CN-1032470-C Sulfur-containing heterocyclic compounds TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1996-08-07 — — CN disclosed
CN-1057654-A Bisphosphonic acid derivatives and preparation thereof and application TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1992-01-08 — — CN disclosed
CN-1045106-A Sulfur heterocyclic compound TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1990-09-05 — — CN disclosed
EP-0034894-B1 2-(1-PIPERAZINYL)-2,4,6-CYCLOHEPTATRIEN-1-ONE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, INTERMEDIATES USED IN THE PROCESSES AND THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE DERIVATIVES AYERST, MCKENNA AND HARRISON INC. (CA) 1984-09-12 — — EP disclosed
EP-0034894-A2 2-(1-Piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives, processes for their preparation, intermediates used in the processes and the preparation thereof and pharmaceutical compositions containing the derivatives AYERST, MCKENNA AND HARRISON INC. (CA) 1981-09-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212968-A1 PHENETHYLAMIDE DERIVATIVES AND THEIR HETEROCYCLIC ANALOGUES HCRTR2, HCRTR1, HRH3 PPARG 1470/4885PPARD 930/4885PPARA 662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback